Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerbitz, K. D.
Right arrow Articles by Brdiczka, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerbitz, K. D.
Right arrow Articles by Brdiczka, D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 2 113-126, Copyright © 1996 by American Diabetes Association


ARTICLES

Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit

KD Gerbitz, K Gempel and D Brdiczka
Institute of Clinical Chemistry, Academic Hospital Schwabing, Munchen, Germany.

Physiologically, a postprandial glucose rise induces metabolic signal sequences that use several steps in common in both the pancreas and peripheral tissues but result in different events due to specialized tissue functions. Glucose transport performed by tissue-specific glucose transporters is, in general, not rate limiting. The next step is phosphorylation of glucose by cell-specific hexokinases. In the beta-cell, glucokinase (or hexokinase IV) is activated upon binding to a pore protein in the outer mitochondrial membrane at contact sites between outer and inner membranes. The same mechanism applies for hexokinase II in skeletal muscle and adipose tissue. The activation of hexokinases depends on a contact site-specific structure of the pore, which is voltage-dependent and influenced by the electric potential of the inner mitochondrial membrane. Mitochondria lacking a membrane potential because of defects in the respiratory chain would thus not be able to increase the glucose-phosphorylating enzyme activity over basal state. Binding and activation of hexokinases to mitochondrial contact sites lead to an acceleration of the formation of both ADP and glucose-6-phosphate (G-6-P). ADP directly enters the mitochondrion and stimulates mitochondrial oxidative phosphorylation. G-6-P is an important intermediate of energy metabolism at the switch position between glycolysis, glycogen synthesis, and the pentose-phosphate shunt. Initiated by blood glucose elevation, mitochondrial oxidative phosphorylation is accelerated in a concerted action coupling glycolysis to mitochondrial metabolism at three different points: first, through NADH transfer to the respiratory chain complex I via the malate/aspartate shuttle; second, by providing FADH2 to complex II through the glycerol-phosphate/dihydroxy-acetone-phosphate cycle; and third, by the action of hexo(gluco)kinases providing ADP for complex V, the ATP synthetase. As cytosolic and mitochondrial isozymes of creatine kinase (CK) are observed in insulinoma cells, the phosphocreatine (CrP) shuttle, working in brain and muscle, may also be involved in signaling glucose-induced insulin secretion in beta-cells. An interplay between the plasma membrane-bound CK and the mitochondrial CK could provide a mechanism to increase ATP locally at the KATP channels, coordinated to the activity of mitochondrial CrP production. Closure of the KATP channels by ATP would lead to an increase of cytosolic and, even more, mitochondrial calcium and finally to insulin secretion. Thus in beta-cells, glucose, via bound glucokinase, stimulates mitochondrial CrP synthesis. The same signaling sequence is used in the opposite direction in muscle during exercise when high ATP turnover increases the creatine level that stimulates mitochondrial ATP synthesis and glucose phosphorylation via hexokinase. Furthermore, this cytosolic/mitochondrial cross-talk is also involved in activation of muscle glycogen synthesis by glucose. The activity of mitochondrially bound hexokinase provides G-6-P and stimulates UTP production through mitochondrial nucleoside diphosphate kinase. Pathophysiologically, there are at least two genetically different forms of diabetes linked to energy metabolism: the first example is one form of maturity-onset diabetes of the young (MODY2), an autosomal dominant disorder caused by point mutations of the glucokinase gene; the second example is several forms of mitochondrial diabetes caused by point and length mutations of the mitochondrial DNA (mtDNA) that encodes several subunits of the respiratory chain complexes. Because the mtDNA is vulnerable and accumulates point and length mutations during aging, it is likely to contribute to the manifestation of some forms of NIDDM.(ABSTRACT TRUNCATED)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
C. D. Berdanier
Linking mitochondrial function to diabetes mellitus: an animal's tale
Am J Physiol Cell Physiol, September 1, 2007; 293(3): C830 - C836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Southworth, K. A. B. Davey, A. Warley, and P. B. Garlick
A reevaluation of the roles of hexokinase I and II in the heart
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H378 - H386.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai
Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
J Appl Physiol, December 1, 2006; 101(6): 1685 - 1692.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Bertoldo, R. R. Pencek, K. Azuma, J. C. Price, C. Kelley, C. Cobelli, and D. E. Kelley
Interactions Between Delivery, Transport, and Phosphorylation of Glucose in Governing Uptake Into Human Skeletal Muscle
Diabetes, November 1, 2006; 55(11): 3028 - 3037.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kumar, R. Verma, and G. P. S. Raghava
Prediction of Mitochondrial Proteins Using Support Vector Machine and Hidden Markov Model
J. Biol. Chem., March 3, 2006; 281(9): 5357 - 5363.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Y. Park, G. H. Choi, H. I. Choi, J. Ryu, C. Y. Jung, and W. Lee
Depletion of Mitochondrial DNA Causes Impaired Glucose Utilization and Insulin Resistance in L6 GLUT4myc Myocytes
J. Biol. Chem., March 18, 2005; 280(11): 9855 - 9864.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. S. Hittel, W. E. Kraus, C. J. Tanner, J. A. Houmard, and E. P. Hoffman
Exercise training increases electron and substrate shuttling proteins in muscle of overweight men and women with the metabolic syndrome
J Appl Physiol, January 1, 2005; 98(1): 168 - 179.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Han, J. H. Bae, S.-Y. Kim, H.-Y. Lee, B.-C. Jang, I.-K. Lee, C.-H. Cho, J.-G. Lim, S.-I. Suh, T.-K. Kwon, et al.
Taurine increases glucose sensitivity of UCP2-overexpressing {beta}-cells by ameliorating mitochondrial metabolism
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1008 - E1018.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Endocr. Rev., October 1, 2004; 25(5): 807 - 830.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani
Elevated Mitochondrial Cytochrome P450 2E1 and Glutathione S-Transferase A4-4 in Streptozotocin-Induced Diabetic Rats: Tissue-Specific Variations and Roles in Oxidative Stress
Diabetes, January 1, 2004; 53(1): 185 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. R. Bruce, M. J. Anderson, A. L. Carey, D. G. Newman, A. Bonen, A. D. Kriketos, G. J. Cooney, and J. A. Hawley
Muscle Oxidative Capacity Is a Better Predictor of Insulin Sensitivity than Lipid Status
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5444 - 5451.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
P. P. Dzeja and A. Terzic
Phosphotransfer networks and cellular energetics
J. Exp. Biol., June 15, 2003; 206(12): 2039 - 2047.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. I. Moreira, M. S. Santos, A. M. Moreno, R. Seica, and C. R. Oliveira
Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid-{beta} Exposure
Diabetes, June 1, 2003; 52(6): 1449 - 1456.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. E. Kelley, J. He, E. V. Menshikova, and V. B. Ritov
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Diabetes, October 1, 2002; 51(10): 2944 - 2950.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. T.W. Choo-Kang, S. Lynn, G. A. Taylor, M. E. Daly, S. S. Sihota, T. M. Wardell, P. F. Chinnery, D. M. Turnbull, and M. Walker
Defining the Importance of Mitochondrial Gene Defects in Maternally Inherited Diabetes by Sequencing the Entire Mitochondrial Genome
Diabetes, July 1, 2002; 51(7): 2317 - 2320.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Ohkubo, A. Yamano, M. Nagashima, Y. Mori, K. Anzai, Y. Akehi, R. Nomiyama, T. Asano, A. Urae, and J. Ono
Mitochondrial Gene Mutations in the tRNALeu(UUR) Region and Diabetes: Prevalence and Clinical Phenotypes in Japan
Clin. Chem., September 1, 2001; 47(9): 1641 - 1648.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. B. Chan, D. De Leo, J. W. Joseph, T. S. McQuaid, X. F. Ha, F. Xu, R. G. Tsushima, P. S. Pennefather, A. M. F. Salapatek, and M. B. Wheeler
Increased Uncoupling Protein-2 Levels in {beta}-cells Are Associated With Impaired Glucose-Stimulated Insulin Secretion: Mechanism of Action
Diabetes, June 1, 2001; 50(6): 1302 - 1310.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K.-S. Park, K.-J. Nam, J.-W. Kim, Y.-B. Lee, C.-Y. Han, J.-K. Jeong, H.-K. Lee, and Y. K. Pak
Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E1007 - E1014.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Novel-Chate, V. Rey, R. Chiolero, P. Schneiter, X. Leverve, E. Jequier, and L. Tappy
Role of Na+-K+-ATPase in insulin-induced lactate release by skeletal muscle
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E296 - E300.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. O.'t Eijnde, B. Ursø, E.A. Richter, P.L. Greenhaff, and P. Hespel
Effect of Oral Creatine Supplementation on Human Muscle GLUT4 Protein Content After Immobilization
Diabetes, January 1, 2001; 50(1): 18 - 23.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
M. Wyss and R. Kaddurah-Daouk
Creatine and Creatinine Metabolism
Physiol Rev, July 1, 2000; 80(3): 1107 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P. F Chinnery, N. Howell, R. M Andrews, and D. M Turnbull
Clinical mitochondrial genetics
J. Med. Genet., June 1, 1999; 36(6): 425 - 436.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Aguilar-Bryan and J. Bryan
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Endocr. Rev., April 1, 1999; 20(2): 101 - 135.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. E. Gerich
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
Endocr. Rev., August 1, 1998; 19(4): 491 - 503.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. P. Murray-McIntosh, B. J. Scrimshaw, P. J. Hatfield, and D. Penny
Testing migration patterns and estimating founding population size in Polynesia by using human mtDNA sequences
PNAS, July 21, 1998; 95(15): 9047 - 9052.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Trueblood and R. Ramasamy
Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H75 - H83.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. P. Dzeja and A. Terzic
Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels
FASEB J, May 1, 1998; 12(7): 523 - 529.
[Abstract] [Full Text]


Home page
CLIN PEDIATRHome page
A. L. Rosenbloom, D. V. House, and W. E. Winter
Non-Insulin Dependent Diabetes Mellitus (NIDDM) in Minority Youth: Research Priorities and Needs
Clinical Pediatrics, February 1, 1998; 37(2): 143 - 152.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Wada and Y. S. Kanwar
Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney
PNAS, January 6, 1998; 95(1): 144 - 149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. B. Allen and C. W. White
Glucose modulates cell death due to normobaric hyperoxia by maintaining cellular ATP
Am J Physiol Lung Cell Mol Physiol, January 1, 1998; 274(1): L159 - L164.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Dunaif
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocr. Rev., December 1, 1997; 18(6): 774 - 800.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. Smith, X.-Y. Hua, D. L. Marsden, D. Liu, N. G. Kennaway, K.-Y. Ngo, and R. H. Haas
Diabetes and Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): Radiolabeled Polymerase Chain Reaction Is Necessary for Accurate Detection of Low Percentages of Mutation
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2826 - 2831.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-A. Simoneau and D. E. Kelley
Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM
J Appl Physiol, July 1, 1997; 83(1): 166 - 171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.